EcoDrugPlus

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSOJAG00000017320
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSOJAG00000003097
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOJAG00000016393
Gene Symbol: IDH2
1 Cross references
207 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSOJAG00000021777
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSOJAG00000009617
Gene Symbol: KDR
1 Cross references
197 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOJAG00000019604
Gene Symbol: KIF5B
1 Cross references
234 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOJAG00000013377
Gene Symbol: KIF5B
1 Cross references
236 Possible Orthologues:

Lectin, Galactoside Binding Soluble 3a

Ensembl ID : ENSOJAG00000014254
Gene Symbol: LGALS3A
1 Cross references
220 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSOJAG00000011015
Gene Symbol: LTB4R
1 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSOJAG00000011004
Gene Symbol: LTB4R2A
1 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSOJAG00000010048
Gene Symbol: LTB4R2B
1 Cross references
167 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSOJAG00000023141
Gene Symbol: KDM1A
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).